1 Institute of Genetic and Biomedical Research , National Research Council (IRGB-CNR), Department of Biomedicine, Milan, Italy .
2 Integrated Systems Engineering S.r.l. (ISENET) , Milan, Italy .
Stem Cells Dev. 2018 Feb 15;27(4):287-295. doi: 10.1089/scd.2017.0158. Epub 2018 Jan 22.
Wolfram syndrome (WFS) is a rare autosomal premature aging syndrome that shows signs of diabetes mellitus, optic atrophy, and deafness in addition to central nervous system and endocrine complications. The frequent form of WFS type 1 (WFS1) harbors causative mutations in the WFS1 gene, whereas the rare form or WFS type 2 (WFS2) involves CISD2. Mutations in these two genes are recognized by a subset of variable clinical symptoms and a set of overlapping features. In this study, we report on the generation of stable human-induced pluripotent stem cells (hiPSCs) derived from primary fibroblasts of a previously reported Italian family with CISD2 mutation (c.103 + 1G>A), occurring in the consensus intron 1 splicing site in two sisters, deleting the first exon of the transcript. The generated hiPSCs provide a cell model system to study the mutation's role in the multisystemic clinical disorders previously described and test eventual drug effects on the specific and associated clinical phenotype.
沃尔弗拉姆综合征(Wolfram syndrome,WFS)是一种罕见的常染色体提前衰老综合征,除中枢神经系统和内分泌并发症外,还表现为糖尿病、视神经萎缩和耳聋。WFS 型 1(WFS1)的常见形式携带有 WFS1 基因突变,而罕见形式或 WFS 型 2(WFS2)则涉及 CISD2。这两种基因突变可引起一组具有不同临床表现的症状和一组重叠的特征。在这项研究中,我们报告了从先前报道的意大利 CISD2 突变(c.103 + 1G>A)家系的原代成纤维细胞中生成稳定的人诱导多能干细胞(hiPSC)的情况,该突变发生在两个姐妹的一致内含子 1 剪接位点,导致转录本的第一个外显子缺失。生成的 hiPSC 提供了一个细胞模型系统,用于研究该突变在先前描述的多系统临床疾病中的作用,并测试特定和相关临床表型的潜在药物作用。